Medical Advocates
HIV Infection/Disease
 
Facial Lipoatrophy
 
General Reports
Diagnosis/Diagnostics
 Treatment

 

 


 

 
HIV Lipoatrophy Main Page   Main New/Newsworthy Home Page  
Last Update: December 03, 2011
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports
       

          Journal Papers, Abstracts, and Commentaries

 
Understanding the experience of reconstructive treatments from the perspective of people who
suffer from facial lipoatrophy: A qualitative study.
Gagnon M.
Int J Nurs Stud. 2011 Nov 28
 Abstract

An Economic Evaluation of Treatments for HIV-associated Facial
Lipoatrophy: A Cost-Utility Analysis.
Peyasantiwong S, Loutfy MR, Laporte A, Coyte PC.
Curr HIV Res. 2010 Apr 29
 Abstract

HIV-Associated Facial Lipoatrophy: Establishment of a Validated Grading Scale.
Funk E, Brissett AE, Friedman CD, Bressler FJ.
 Laryngoscope. 2007 Jun 29;
 Abstract
 
Facial lipodystrophy in patients with HIV infections troublesome to treat  
 Walther RA.
Lakartidningen 2002 Sep 26;99(39):3826-9
 Abstract

Facial Atrophy in HIV-Related Fat Redistribution Syndrome: Anatomic Evaluation and
Surgical Reconstruction.
 Talmor M, Hoffman LA, LaTrenta GS.
Ann Plast Surg 2002 Jul;49(1):11-7
 Abstract

  

         Conference Reports, Abstracts, and Posters
 
  Study of the level of autoesteem in VIH + persons with facial lipoatrophy through facial
restoration without surgery (infiltrated)
U García Uribe
(15IAC)
 Abstract
 
  Psychological assessment of HIV-infected patients with facial lipoatrophy
before and after reparatory treatment
CR Fumaz, JA Muñoz-Moreno, M J Ferrer, et al
(15IAC)
 Abstract
 
Psycho-social impact of facial lipoatrophy in HIV+ patients on antiretroviral
treatment.
A Barata, P Domingo, MA Sambeat, et al
(15IAC)
 Abstract
 
Characterization and quantification of the facial lipoatrophy due to HAART
based on the facial lipoatrophy severity index
D Arakaki, JN Lima, BM Trope, et al
(15IAC)
 Abstract

Diagnosis/Diagnostics
       
         Conference Reports, Abstracts, and Posters
 
 
Sonographic Assessment of Facial HIV-Related Lipoatrophy.
Petrone A, Rizzi EB, Schininà V, et al 
Dermatol Surg. 2009 May 15
 Abstract

Objective Assessment of Facial Lipoatrophy Changes in a Cohort of HIV-Infected Patients Taking
Combination Antiretroviral Therapy.
Yang Y, Yap M, Oo Tha N, Paton1 NI.
HIV Clin Trials. 2008 Jan 1;9(6):399-406
 Abstract
 
Validation of three-dimensional laser scanning for the assessment of facial fat changes.
Paton NI, Yang Y, Sitoh YY, Oo Tha N.
HIV Med. 2007 Nov;8(8):498-503.
 Abstract
 
Changes in Facial Fat in HIV-Related Lipoatrophy, Wasting, and Weight Gain Measured
by Magnetic Resonance Imaging.
Paton NI, Yang Y, Tha NO, Sitoh YY.
HIV Clin Trials. 2007 Jul-Aug;8(4):227-34.
 Abstract
 
Laser scanning as a tool for assessment of HIV-related facial lipoatrophy: evaluation of a
ccuracy and reproducibility.
 Yang Y, Paton NI.
HIV Med. 2005 Sep;6(5):321-5.
 Abstract
 
Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-
controlled trial.
 Carey D, Wand H, Martin A, Rothwell S, et al 
AIDS. 2005 Aug 12;19(12):1325-1327.
 Abstract

MRI Measurement of the Volume and Anatomical Distribution of Facial Fat
Depletion in Lipodystrophy and Wasting
 N Paton, Y Yang, Y Sitoh, O Naing
 (12 CROI)
 Abstract

HIV Lipoatrophy Main Page   Main New/Newsworthy Home Page  

Facial Lipoatrophy